{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T14:10:29Z","timestamp":1774534229185,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.numecd.2009.10.016","type":"journal-article","created":{"date-parts":[[2010,2,13]],"date-time":"2010-02-13T04:32:55Z","timestamp":1266035575000},"page":"217-223","source":"Crossref","is-referenced-by-count":10,"title":["Cardiovascular events in patients with antiphospholipid antibodies: Strategies of prevention"],"prefix":"10.1016","volume":"20","author":[{"given":"A.","family":"Tufano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Guida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.N.D.","family":"Di Minno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"De Gregorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Cerbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Di Minno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2009.10.016_bib1","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMra002974","article-title":"The antiphospholipid syndrome","volume":"346","author":"Levine","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2009.10.016_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ncprheum0017","article-title":"Diagnosis of antiphospholipid syndrome","volume":"1","author":"Bertolaccini","year":"2005","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.numecd.2009.10.016_bib3","first-page":"195","article-title":"Update on antiphospholipid syndrome","volume":"66","author":"Lockshin","year":"2008","journal-title":"Bull NYU Hosp Joint Dis"},{"key":"10.1016\/j.numecd.2009.10.016_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10238-003-0016-x","article-title":"Antiphospholipid syndrome","volume":"3","author":"Cuadrado","year":"2003","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.numecd.2009.10.016_bib5","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1111\/j.1538-7836.2005.01359.x","article-title":"Pathophysiology of the antiphospholipid syndrome","volume":"3","author":"De Groot","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.numecd.2009.10.016_bib6","first-page":"1560","article-title":"Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals","volume":"31","author":"Giron-Gonzalez","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.numecd.2009.10.016_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0049-3848(95)00001-1","article-title":"Antiphospholipid-protein antibodies: laboratory detection and clinical relevance","volume":"78","author":"Triplett","year":"1995","journal-title":"Thromb Res"},{"key":"10.1016\/j.numecd.2009.10.016_bib8","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/jama.295.9.1050","article-title":"Management of antiphospholipid antibody syndrome. A systematic review","volume":"295","author":"Lim","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2009.10.016_bib9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s11739-008-0193-4","article-title":"Aspirin in asymptomatic patients with a confirmed positivity of antiphospholipid antibodies","volume":"3","author":"Basili","year":"2008","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.numecd.2009.10.016_bib10","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0002-9343(96)00060-5","article-title":"Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies. A four-year prospective study from the Italian registry","volume":"100","author":"Finazzi","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.numecd.2009.10.016_bib11","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1538-7836.2005.01295.x","article-title":"A prospective study of antibodies to anti \u03b22-glycoprotein I and prothrombin and risk of thrombosis","volume":"3","author":"Forastiero","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.numecd.2009.10.016_bib12","doi-asserted-by":"crossref","first-page":"997","DOI":"10.7326\/0003-4819-117-12-997","article-title":"Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis","volume":"117","author":"Ginsburg","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.numecd.2009.10.016_bib13","first-page":"2531","article-title":"Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus","volume":"29","author":"Somers","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.numecd.2009.10.016_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/0961203306074767","article-title":"Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients","volume":"16","author":"Tarr","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.numecd.2009.10.016_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/art.24232","article-title":"Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies","volume":"61","author":"Tektonidou","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.numecd.2009.10.016_bib16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1646452","article-title":"The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a cross-sectional study","volume":"66","author":"Long","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.numecd.2009.10.016_bib17","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJM199504133321504","article-title":"The management of thrombosis in the antiphospholipid-antibody syndrome","volume":"332","author":"Khamasiita","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2009.10.016_bib18","first-page":"630","article-title":"Heparin therapy for pregnancy women with lupus anticoagulant or anticardiolipin antibodies","volume":"75","author":"Rosove","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.numecd.2009.10.016_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.7326\/0003-4819-117-4-303","article-title":"Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients","volume":"117","author":"Rosove","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.numecd.2009.10.016_bib20","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/ard.52.9.689","article-title":"Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment","volume":"52","author":"Derksen","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.numecd.2009.10.016_bib21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/ncprheum0432","article-title":"The antiphospholipid syndrome as a disorder initiated by inflammation: implications for the therapy of pregnant patients","volume":"3","author":"Salmon","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.numecd.2009.10.016_bib22","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1056\/NEJMoa035241","article-title":"A comparison of two intensities of warfarin for the prevention or recurrent thrombosis in patients with the antiphospholipid antibody syndrome","volume":"349","author":"Crowter","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2009.10.016_bib23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-127-3-199708010-00001","article-title":"Monitoring warfarin therapy in patients with lupus anticoagulants","volume":"127","author":"Moll","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.numecd.2009.10.016_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11739-008-0203-6","article-title":"Aspirin thromboprophylaxis of asymptomatic antiphospholipids-positive subjects","volume":"4","author":"Galli","year":"2009","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.numecd.2009.10.016_bib25","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/1529-0131(200106)44:6<1466::AID-ART242>3.0.CO;2-C","article-title":"High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin","volume":"44","author":"Erkan","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.numecd.2009.10.016_bib26","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1002\/art.22663","article-title":"A randomized double-blind placebo-controlled trial in asymptomatic antiphospholipid antibody positive individuals","volume":"56","author":"Erkan","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.numecd.2009.10.016_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11739-008-0170-y","article-title":"Aspirin in asymptomatic patients with confirmed positivity of anticardiolipin antibodies? Yes (in some cases)","volume":"3","author":"Gerosa","year":"2008","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.numecd.2009.10.016_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11739-008-0169-4","article-title":"Aspirin in asymptomatic patients with confirmed positivity of anticardiolipin antibodies? No","volume":"3","author":"Finazzi","year":"2008","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.numecd.2009.10.016_bib29","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/0003-4819-147-8-200710160-00004","article-title":"Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial","volume":"147","author":"Glynn","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.numecd.2009.10.016_bib30","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1046\/j.1365-2141.2000.01964.x","article-title":"The G1691A mutation of factor V, but not the G20210A mutation of factor II or the C677T mutation of methylenethetrahydrofolate reductase genes, is associated with venous thrombosis in patients with lupus anticoagulants","volume":"108","author":"Galli","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.numecd.2009.10.016_bib31","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2002-02-0441","article-title":"Lupus anticoagulants are stronger risk factors of thrombosis than anticardiolipin antibodies in the Antiphospholipid syndrome: a systematic review of the literature","volume":"101","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.numecd.2009.10.016_bib32","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1182\/blood-2002-11-3334","article-title":"Anti \u03b22-glycoprotein I, antiprothrombin antibodies and the risk of thrombosis in the antiphospholipids syndrome","volume":"102","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.numecd.2009.10.016_bib33","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1055\/s-0037-1615066","article-title":"The contribution of anti-prothrombin antibodies to the lupus anticoagulant activity-discrimination between functional and non-function anti-prothrombin antibodies","volume":"79","author":"Horbach","year":"1998","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.numecd.2009.10.016_bib34","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1182\/blood-2004-03-1107","article-title":"\u03b22-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome","volume":"104","author":"De Laat","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.numecd.2009.10.016_bib35","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/blood-2004-09-3387","article-title":"IgG antibodies that recognize epitope Gly40-Arg43 in domain I of \u03b22-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis","volume":"105","author":"De Laat","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.numecd.2009.10.016_bib36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/00016349209006228","article-title":"Lupus anticoagulant and anticardiolipin antibodies in an obstetric population","volume":"71","author":"Rix","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.numecd.2009.10.016_bib37","first-page":"175","article-title":"A prospective epidemiological study on the occurrence of antiphospholipids antibody: the Montpellier antiphospholipids (MAP) study","volume":"24","author":"Schved","year":"1994","journal-title":"Haemostasis"},{"key":"10.1016\/j.numecd.2009.10.016_bib38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11739-008-0222-3","article-title":"25 years of the antiphospholipids syndrome; lights and shadows on the primary prophylaxis of asymptomatic patients with confirmed positivity of antiphospholipids antibodies","volume":"4","author":"Andreoli","year":"2009","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.numecd.2009.10.016_bib39","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1002\/art.11332","article-title":"New approaches to prevention of thrombosis in the antiphospholipid syndrome: hopes, trials, and tribulations","volume":"48","author":"Ras","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.numecd.2009.10.016_bib40","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood-2008-03-144204","article-title":"Hydroxychloroquine directly reduces the binding of antiphospholipid antibody- \u03b22-glycoprotein I complexes to phospholipid bilayers","volume":"112","author":"Rand","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.numecd.2009.10.016_bib41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.numecd.2009.03.022","article-title":"The emerging role of atherosclerotic cardiovascular disease in systemic lupus erythematosus","volume":"19","author":"Schillaci","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2009.10.016_bib42","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.numecd.2008.09.009","article-title":"High prevalence of subclinical abnormalities in patients with systemic lupus erythematosus in spite of a very low clinical damage index","volume":"19","author":"Palmieri","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475309002749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475309002749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T19:28:32Z","timestamp":1558812512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475309002749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0939475309002749"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2009.10.016","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}